These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 17990111

  • 21. [Invalidating and recurrent gastrointestinal bleeding caused by intestinal angiodysplasia: treatment with thalidomide].
    Serralta de Colsa D, Arjona Medina I, García Marín A, Sanz Sánchez M, Turégano Fuentes F.
    Rev Esp Enferm Dig; 2008 May; 100(5):306-7. PubMed ID: 18662087
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Angiogenesis and vascular malformations: antiangiogenic drugs for treatment of gastrointestinal bleeding.
    Bauditz J, Lochs H.
    World J Gastroenterol; 2007 Dec 07; 13(45):5979-84. PubMed ID: 18023086
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Successful treatment of thalidomide for recurrent bleeding due to gastric angiodysplasia in hereditary hemorrhagic telangiectasia.
    Wang XY, Chen Y, Du Q.
    Eur Rev Med Pharmacol Sci; 2013 Apr 07; 17(8):1114-6. PubMed ID: 23661527
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Thalidomide for the treatment of angiodysplasia in a patient with acute upper gastrointestinal haemorrhage.
    Bond A, Ahmed W.
    BMJ Case Rep; 2016 Jan 20; 2016():. PubMed ID: 26791122
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Somatostatin analogues in the treatment of bleeding GI-angiodysplasias].
    Boesby L, Christensen NJ, Kristensen LO.
    Ugeskr Laeger; 2008 Mar 10; 170(11):958. PubMed ID: 18397628
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pharmacological treatment of gastrointestinal bleeding due to angiodysplasias: A position paper of the Italian Society of Gastroenterology (SIGE).
    Nardone G, Compare D, Martino A, Rocco A.
    Dig Liver Dis; 2018 Jun 10; 50(6):542-548. PubMed ID: 29610020
    [Abstract] [Full Text] [Related]

  • 37. Thalidomide for treatment of severe intestinal bleeding.
    Bauditz J, Schachschal G, Wedel S, Lochs H.
    Gut; 2004 Apr 10; 53(4):609-12. PubMed ID: 15016759
    [Abstract] [Full Text] [Related]

  • 38. Long-term treatment with thalidomide for severe recurrent hemorrhage from intestinal angiodysplasia in Glanzmann Thrombasthenia.
    Paciullo F, Fierro T, Calcinaro F, Zucca Giucca G, Gresele P, Bury L.
    Platelets; 2021 Feb 17; 32(2):288-291. PubMed ID: 32200672
    [Abstract] [Full Text] [Related]

  • 39. Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias?
    Bowcock SJ, Patrick HE.
    Br J Haematol; 2009 Jul 17; 146(2):220-2. PubMed ID: 19438503
    [No Abstract] [Full Text] [Related]

  • 40. Multicentre, open-label, randomised, parallel-group, superiority study to compare the efficacy of octreotide therapy 40 mg monthly versus standard of care in patients with refractory anaemia due to gastrointestinal bleeding from small bowel angiodysplasias: a protocol of the OCEAN trial.
    Grooteman KV, van Geenen EJ, Drenth JP.
    BMJ Open; 2016 Sep 12; 6(9):e011442. PubMed ID: 27619827
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.